What is NDC 73562-113?

73562-113 is the product NDC for Zenpep, Pancrelipase lipase 3000 [USP'U]/1 + 2 more ingredients capsule, delayed release, listed with the FDA by Aimmune Therapeutics, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Zenpep (Pancrelipase lipase, pancrelipase protease, pancrelipase amylase).

What is the active ingredient?

Pancrelipase lipase, Pancrelipase protease, Pancrelipase amylase.

Aimmune Therapeutics, Inc., NDC labeler code 73562. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Zenpep?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Zenpep NDC 73562-113 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)73562-113Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73562-0113Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
73562-113-01	7356201130173562011301	100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (73562-113-01)Marketed from Apr 1, 2021
73562-113-10	7356201131073562011310	100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (73562-113-10)Marketed from Jan 1, 2021 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zenpep
Generic name (nonproprietary): pancrelipase lipase, pancrelipase protease, pancrelipase amylase
Active ingredients: Pancrelipase lipase — 3000 [USP'U]/1Pancrelipase protease — 10000 [USP'U]/1Pancrelipase amylase — 14000 [USP'U]/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Aimmune Therapeutics, Inc.NDC labeler code 73562
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 022210
Marketing start: Jan 1, 2021
Listing expires: Dec 31, 2026
Identifiers: Product ID 73562-113_6b24ef38-2c65-4b1d-804a-a8301db084e6SPL ID 6b24ef38-2c65-4b1d-804a-a8301db084e6SPL set ID 7f16f2d4-8df6-4bd7-ac10-56994fa257b0RxCUI 1594671, 1594673, 1595290, 1595292, 1595455, 1595457, 1595460, 1595462, 1595471, 1595473, 1595476, 1595478, 1995477, 1995479, 2669470, 2669472UNII 8MYC33932O, 3560D81V50, YOJ58O116EUPC 0373562115018, 0373562110013

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N473562011301 followed by a unit qualifier and the quantity

Package 73562-0113-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 14, 2025.

Indications (excerpt from the label)

ZENPEP ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients. ZENPEP ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73562-113

What is NDC 73562-113?: 73562-113 is the product NDC for Zenpep, Pancrelipase lipase 3000 [USP'U]/1 + 2 more ingredients capsule, delayed release, listed with the FDA by Aimmune Therapeutics, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Zenpep (Pancrelipase lipase, pancrelipase protease, pancrelipase amylase).
What is the active ingredient?: Pancrelipase lipase, Pancrelipase protease, Pancrelipase amylase.
Who is the labeler?: Aimmune Therapeutics, Inc., NDC labeler code 73562. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Zenpep?: 7 other product NDCs are listed under this name. See all Zenpep NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Zenpep NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 10000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-110	73562-0110-0173562-0110-10
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 5000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-115	73562-0115-0173562-0115-10
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 15000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-111	73562-0111-01
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 20000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-112	73562-0112-01
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 40000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-114	73562-0114-0173562-0114-12
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 25000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-116	73562-0116-0173562-0116-12
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 60000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-117	73562-0117-0173562-0117-12

Other NDCs under BLA 022210

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 022210
Product	Strength	Form · route	Labeler	Product NDC
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 10000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-110
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 15000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-111
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 20000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-112
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 40000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-114
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 5000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-115
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 25000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-116
Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase	Pancrelipase lipase 60000 [USP'U]/1 + 2 more ingredients	Capsule, Delayed releaseOral	Aimmune Therapeutics, Inc.	73562-117